In this episode, Thomas Debray and I dive back into the intriguing world of personalized medicine.

We explore the advancements, and hurdles in customizing patient care.

Have you ever wondered what makes developing personalized treatment strategies so challenging, especially when traditional studies may not always provide clear answers for individual patients?

Why are crossover trials unique, yet not entirely suited for generalizing results to new patients?

And how does the standard phase three study design fall short in the quest for personalization?

Join us as we navigate these complex questions, shedding light on the opportunities and obstacles that lie ahead in making personalized medicine a reality for all.

We also dive into these following key points: